“"Assisted methadone intake in community pharmacies requires preparation, rigor, and discretion. Pharmacists are prepared to assume this responsibility, in close coordination with clinical teams, ensuring safe, humane, and person-centered care, respecting their dignity, privacy, and autonomy."
Community pharmacies now dispensing methadone for opioid addiction treatment
The program launches in seven municipalities, aiming to facilitate treatment access, reduce travel, and promote social reintegration.
By Rui Tavares Fonseca
••2 min read
AI
Generic image of a community pharmacy in Portugal, with a pharmacist dispensing medication in a private area.
Since November 1st, community pharmacies in seven Portuguese municipalities have begun dispensing methadone to individuals undergoing opioid addiction treatment, in a program designed to improve access and reduce travel.
The Program for the Treatment of Opioid Addiction with Methadone Hydrochloride in Community Pharmacies is launching in the municipalities of Albufeira, Loulé, Portalegre, Portimão, São Brás de Alportel, Santiago do Cacém, and Vila do Bispo, with plans for progressive expansion nationwide. This initiative stems from a protocol involving the Institute for Addictive Behaviors and Dependencies (ICAD), INFARMED, the National Association of Pharmacies (ANF), the Association of Pharmacies of Portugal (AFP), and the Order of Pharmacists.
Methadone is administered at a participating pharmacy, based on referrals and in coordination with the clinical teams managing each patient. Prescription and clinical supervision remain the responsibility of specialized structures, which maintain constant contact with the pharmacies. Involved pharmacists have received specific training to ensure safe administration in a private space that protects the privacy, confidentiality, and dignity of each person.
The Order of Pharmacists views this program as recognition of the pharmacist as a frontline healthcare professional, capable of integrating public health responses in coordination with the National Health Service. The Order participated in drafting the protocol and developed a Good Pharmaceutical Practice Standard and specific training for the involved pharmacists, ensuring technical quality, safety, and adherence to professional ethical principles.
The President of ICAD, Joana Teixeira, noted that in 2024, approximately 24,100 people were in outpatient treatment for drug-related issues within the public network, with heroin being the primary substance in over 13,200 cases. "Collaboration with pharmacies allows us to expand our support capacity and foster recovery and social reintegration pathways," she stated.
The program aligns with the objectives of the National Plan for the Reduction of Addictive Behaviors and Dependencies 2030, by facilitating access to treatment and promoting recovery and social reintegration.
Based on information from the official source: Ordem dos Farmacêuticos (02/11/2026)



